COA
Batch-specific COA
Request this file through the inquiry path below.
B2B Tirzepatide / LY3298176 60mg lyophilized peptide vial supply for qualified buyers, with documentation review, traceability, custom fill quantity, and packaging discussion.
Specifications
Documents Available
COA
Request this file through the inquiry path below.
Analytical File
Request this file through the inquiry path below.
Analytical File
Request this file through the inquiry path below.
Safety Document
Request this file through the inquiry path below.
Overview
Tirzepatide / LY3298176 60mg is listed here as a lyophilized peptide vial supply item for qualified B2B sourcing projects. WUMO Peptide supports business buyers that need documentation review, batch traceability, packaging discussion, and supply feasibility confirmation before procurement planning.
The 60mg specification refers to a project-based vial fill quantity for B2B sourcing discussion. It is not product-use guidance, personal-use guidance, or medical advice.
This page is not a retail page for individuals. It is designed for qualified business buyers, distributors, labs, OEM/ODM teams, formulation developers, and legally authorized importers.
All technical information is subject to batch-specific COA and project confirmation.
Details
Tirzepatide, also known as LY3298176, can be discussed as a 60mg lyophilized peptide vial project where documentation, batch consistency, sourcing transparency, and project-specific specifications are required. WUMO supports business-side evaluation, document checks, packaging planning, and supply discussions based on buyer qualification, destination market, and applicable import or distribution expectations.
WUMO does not provide medical guidance, personal-use information, product-use instructions, disease-related claims, or end-user outcome claims. All discussions are limited to qualified B2B sourcing, documentation review, and project feasibility.
| Item | Information |
|---|---|
| Product Name | Tirzepatide, subject to batch-specific COA and project confirmation |
| Alternative Name | LY3298176, subject to batch-specific COA and project confirmation |
| CAS Number | 2023788-19-2, subject to batch-specific COA and project confirmation |
| Molecular Formula | C225H348N48O68, subject to batch-specific COA and project confirmation |
| Molecular Weight | 4813.45, subject to batch-specific COA and project confirmation |
| Product Format | 60mg lyophilized peptide vial |
| Fill Quantity | 60mg/vial for B2B project discussion only |
| Supply Focus | B2B peptide vial supply and project-based sourcing |
| Documentation | COA, HPLC, MS, SDS/MSDS, and batch traceability records where available |
WUMO focuses on documentation-driven supply for B2B peptide projects. For Tirzepatide / LY3298176 60mg lyophilized peptide vial projects, available quality documentation may include batch-specific COA, HPLC report, MS report, SDS/MSDS, and traceability information. Documentation scope may vary by batch, project type, packaging arrangement, buyer requirements, and destination market.
For a structured procurement review path, read the Tirzepatide 60mg B2B Sourcing Guide.
Tirzepatide / LY3298176 60mg information on this page is provided for qualified B2B sourcing, documentation review, and project discussion only. The 60mg specification refers to a vial fill quantity for project discussion and is not medical advice or product-use instruction.
This page is not intended for retail sale to individuals or individual product-use guidance. WUMO Peptide does not provide medical guidance, disease-related claims, product-use instructions, end-user recommendations, or end-user outcome claims. Final use, importation, registration, labeling, and local market compliance are the buyer responsibility.
All technical information is subject to batch-specific COA and project confirmation.
FAQ
Tirzepatide, also known as LY3298176, is listed on this page as a 60mg lyophilized peptide vial supply item for qualified B2B sourcing projects. WUMO provides business-side sourcing support, documentation review, packaging discussion, and batch-specific specification confirmation. This page does not provide medical advice, personal-use guidance, product-use instructions, or retail sales to individuals.
On this page, 60mg refers to a project-based vial fill quantity for qualified B2B sourcing discussion. It is not product-use instruction, personal-use guidance, or medical advice. Buyers should confirm their required fill quantity, documentation needs, packaging format, destination market, and local compliance responsibilities before quotation.
WUMO can discuss Tirzepatide / LY3298176 60mg lyophilized peptide vial projects with qualified business buyers, distributors, labs, OEM/ODM teams, formulation developers, and legally authorized importers. Supply feasibility, MOQ, lead time, packaging format, and documentation scope must be confirmed case by case.
Qualified buyers may request batch-specific COA, HPLC report, MS report, SDS/MSDS, and traceability information where available. The final documentation package depends on the batch, project type, packaging arrangement, buyer requirements, and destination market.
Buyers should provide company name, buyer type, destination country, required form, target fill quantity, estimated monthly forecast, required documents, packaging preference, target lead time, and import or distribution compliance confirmation where applicable.
WUMO can discuss neutral-label and private-label vial packaging support for qualified B2B projects. Labeling, claims, market registration, and local compliance requirements are the buyer responsibility and must be reviewed before production planning.
Raw material supply usually focuses on peptide material evaluation and batch documentation. A 60mg lyophilized vial project adds project-based fill quantity, vial configuration, stopper and packaging discussion, batch coding, and distributor/OEM presentation requirements.
Tirzepatide sourcing discussions should clarify whether the buyer is requesting USD/g, USD/vial, USD/box, or a project-based vial package. Fill quantity, packaging, documentation, MOQ, and lead time can significantly affect the quotation structure.
No. This page is for qualified B2B sourcing, documentation review, and project discussion only. WUMO does not provide medical guidance, personal-use information, product-use instructions, disease-related claims, or retail sales to individuals through this website.
WUMO can discuss available technical files for qualified B2B buyers, including COA, HPLC, MS, SDS/MSDS, and batch traceability records where available. File availability and scope should be confirmed by batch, project format, buyer requirement, and destination market.
Use this form for pricing, technical files, sample requests, or project discussion for this product.
Need COA, SDS/MSDS, or specifications? Choose "Technical document request" in the inquiry form or mention the file name in your message.